ALBANJI, MORUJ HASSAN, et al. “IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION”. TPM – Testing, Psychometrics, Methodology in Applied Psychology, vol. 32, no. S1 (2025): Posted 12 May, Aug. 2025, pp. 738-44, https://tpmap.org/submission/index.php/tpm/article/view/249.